On Monday, I named the money backing Nazir Razak’s Ikhlas Capital as it closes its second fund.
I also published that the PE firm is looking to pull off a healthcare roll-up with PMG Healthcare as the anchor.
What I didn’t do was step back to see some of the inner workings of a fund whose founders bring an elite pedigree to the deal table.
And to ask: what is a fund like Ikhlas actually selling to all that patient, government-linked capital?
I’ll begin with the most obvious starting point: the old boys’ club.
Brainjam is a space for founding members where I post loose notes and other musings that do not make the cut for a full-on newsletter.
If you’re still on the fence, no worries.
The section is a mainstay and (for want of a better word) a value-add for subscribers who decide to take that leap of faith in purchasing the highest tier of the newsletter.
